Figure 2.
Pooled 8-week TI rates in patients with TD LR-MDSs treated with luspatercept. This forest plot displays the pooled 8-week TI rates across individual studies evaluating Lusp in patients with TD LR-MDSs. Each square represents the point estimate of TI rate for an individual study, with the horizontal bars indicating 95% CIs. The size of the squares reflects the weight of each study in the meta-analysis. The diamond at the bottom represents the overall pooled estimate, with its width indicating the 95% CI. A random-effects model was used due to interstudy heterogeneity. Lusp, luspatercept.